An in-Dept View of the Deals and Alliances Made in the Bioinformatics Industry.DUBLIN Dublin, city, Republic of Ireland Dublin, Irish Baile Átha Cliath, county borough (1991 pop. 915,516), Leinster, capital of the Republic of Ireland, on Dublin Bay at the mouth of the Liffey River. , Ireland Ireland, Irish Eire (âr`ə) [to it are related the poetic Erin and perhaps the Latin Hibernia], island, 32,598 sq mi (84,429 sq km), second largest of the British Isles. -- Research and Markets (http://www.researchandmarkets.com/reports/c34012) has announced the addition of PartneringReview 2006: BioPharma Deal Making By Industry Sector - Bioinformatics Using computers in biological research to analyze or predict the composition of molecules (nucleic acids, proteins, etc.) and model biologic systems. Bioinformatics is most prominent in the Human Genome Project, which has recorded the three billion chemical base pairs that make up the to their offering. This report contains a subset A group of commands or functions that do not include all the capabilities of the original specification. Software or hardware components designed for the subset will also work with the original. of the data provided in "PartneringReview 2006: BioPharma Deal Making ", which is a comprehensive summary of the years BioPharma deals, providing a broad perspective of the deal making activity during 2005: --Want to know what your competitors are doing? --Want to benchmark A performance test of hardware and/or software. There are various programs that very accurately test the raw power of a single machine, the interaction in a single client/server system (one server/multiple clients) and the transactions per second in a transaction processing system. your deals against others in your therapeutic area? --See how the finances of different deal types compare? --Want to know what the early, clinical and late stage developments are? --Interested in new merger and acquisition activity over 2005? --Curious about financing investments from lead investors? PartneringReview 2006: BioPharma Deal Making provides: --Fully categorized cat·e·go·rize tr.v. cat·e·go·rized, cat·e·go·riz·ing, cat·e·go·riz·es To put into a category or categories; classify. cat overviews of deals, alliances and financings --Financial information where disclosed --Specialized indexes including deal type, therapy area, industry sector, financials and stage of development --An alphabetical index of company activity --Interactive PDF (Portable Document Format) The de facto standard for document publishing from Adobe. On the Web, there are countless brochures, data sheets, white papers and technical manuals in the PDF format. format for easy exploration This section of the report provides an in depth view into the bioinformatic deals and alliances announced in 2005, in a clear and accessible format. The report analyzes deals announced by company, therapy focus and development stage. Every deal is fully categorized, includes a detailed description, and includes financials such as headline value, upfront and milestone payments, where disclosed. Each deal is annotated with a deal number, such as #43. This number links to the full deal in the deal listing at the rear of each report. Topics Covered Introduction About Partneringreview Full contents of Partneringreview 2006 Review of deal making in 2005 Deals announced by industry sector Bioinformatics Deals in the bioinformatics sector by company Deals in the bioinformatics sector by therapy focus Deals in the bioinformatics sector by development stage List of deals Glossary A term used by Microsoft Word and adopted by other word processors for the list of shorthand, keyboard macros created by a particular user. See glossaries in this publication and The Computer Glossary. Tables Table 7 Top bioinformatics sector dealmaking companies in 2005 Figures Fig. i.1 Deals announced by sector Fig. 7.1 Announcements in the bioinformatics sector by company Fig. 7.2 Announcements in the bioinformatics sector by therapy area Fig. 7.3 Announcements in the bioinformatics sector by stage of development For more information visit http://www.researchandmarkets.com/reports/c34012 |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion